Earth Science Tech, Inc. reports news on its role as a diversified healthcare and wellness holding company with OTC-traded common stock. Recurring updates cover its compounding pharmacy operations, including RxCompoundStore.com and Mister Meds, and telemedicine platforms such as Peaks Curative, DOConsultation, MOCTeledoc and MyOnlineConsultation.com.
Company announcements also address financial results, public-company governance, auditor and investor-relations changes, industry-classification updates, FINRA quotation clearance, and portfolio activity outside healthcare through Avenvi real estate and asset management and MagneChef direct-to-consumer products.
Earth Science Tech (ETST) has uplisted its shares to the OTCQB Venture Market, with trading on this tier effective September 17, 2026.
The OTCQB serves entrepreneurial and growth-stage companies that meet specified financial and reporting standards, complete annual verification, and comply with management certification requirements. The company said this market framework is intended to enhance transparency and provide investors with a more trusted trading environment. Real-time quotes and market data for Earth Science Tech are available on www.otcmarkets.com and through its investor relations page.
Earth Science Tech operates as a diversified holding company in the health and wellness sector, aiming to build a vertically integrated healthcare platform spanning compounding pharmacies, telemedicine, clinical support, and direct-to-patient fulfillment, supported by real estate, asset management, and consumer products operations.
Earth Science Tech (OTC: ETST) reported voting results from its first Annual Meeting of Stockholders held virtually on August 31, 2026. Shareholders approved a Board‑discretionary reverse stock split authorization, valid for 12 months, to be used only if needed to meet minimum bid price requirements for a potential uplisting to a national securities exchange.
Investors also authorized an independent Special Committee of the Board to negotiate the retirement of the Series B Preferred Stock, which would remove the dual-class super‑voting structure. Shareholders approved a non‑dilutive, cash‑only executive compensation approach with a three‑year review cycle, re‑elected all seven directors, and ratified Semple, Marchal & Cooper, LLP as independent auditor.
Earth Science Tech (OTC: ETST) announced the acquisition of Zoolzy LLC, a Doral, Florida-based wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products. Zoolzy operates from a 3,684-square-foot facility and is being integrated into ETST’s vertically integrated healthcare platform.
According to the company, the transaction is designed to be highly accretive, with three main growth drivers. First, internalizing wholesale API procurement is expected to give ETST’s compounding pharmacies access to more competitive raw-material pricing, supporting higher profit margins. Second, broader access to novel APIs should enhance custom compounding capabilities. Third, the deal provides immediate procurement access to common veterinary medications, enabling a strategic push into animal health through unique, flavored, and easier-to-administer veterinary therapeutics, led by management with experience in exotic wildlife.
Earth Science Tech (OTC: ETST) has acquired Meduvo LLC, a La Verne, California-based compounding pharmacy, creating a strategic West Coast hub and expanding its pharmacy network to 34 U.S. jurisdictions. Regulatory approvals for additional states are being pursued to move toward nationwide dispensing coverage.
Meduvo currently operates from a 2,000-square-foot facility focused on non-sterile compounded medications. According to Earth Science Tech, the company plans facility upgrades to meet sterile compounding standards and is targeting full regulatory certification for sterile compounding by the end of 2028, supporting its vertically integrated health and wellness platform.
Earth Science Tech (OTC: ETST) reported fiscal first quarter 2027 results for the period ended June 30, 2026. Revenue rose to $9.0 million from $8.8 million, while net income increased 57% to $715,697. Diluted EPS more than tripled to $0.003 from $0.001.
Net cash provided by operating activities grew 108.4% to $707,131. Total assets reached $10.4 million, up from $7.8 million a year earlier. The company repurchased and retired over 3.7 million shares of common stock, compared to 505,000 in the prior-year quarter, without adding debt. All key operating subsidiaries were profitable, supported by expanding compounding pharmacy licensing and ongoing evaluation of opportunities in telehealth and pharmacy fulfillment.
Management plans to discuss these results and strategic initiatives, including proposed cancellation of Series B preferred stock and evaluation of a potential exchange uplisting, at the Annual Meeting on August 31, 2026.
Earth Science Tech (OTC: ETST) reported full-year results for fiscal 2026 ended March 31, 2026. Revenue was $35.7 million (+8%), gross profit $25.5 million (+5%), and net income $3.6 million (+11%). Total assets rose to $9.0 million (+27%).
The company generated positive operating cash flow, added no new debt, and repurchased and retired 4.0 million shares in fiscal 2026 and over 3.1 million shares in fiscal Q1 2027, supporting its shareholder value strategy.
Earth Science Tech (OTC: ETST) released its annual shareholder letter for the fiscal year ended March 31, 2026. The company highlights cash flow positive operations across its platform, segment reporting changes, and debt-free expansion.
Key milestones include share repurchases, Health/Wellness growth, and Peaks Curative revenue surpassing $2 million in the first week of fiscal Q4 2026.
Earth Science Tech (OTC:ETST)/b) announced that CEO and Chairman Giorgio R. Saumat will present at the .
The presentation is scheduled for Wednesday, June 17, 2026, at 9:00 a.m. PT / 12:00 p.m. ET at the Bellagio Resort & Hotel and will include a live Q&A and one-on-one investor meetings.
Earth Science Tech (OTC: ETST) launched MyOnlineConsultation.com via MOCTeledoc, LLC, completing a vertically integrated telehealth-to-pharmacy ecosystem on March 24, 2026.
MOCTeledoc exited beta as cash-flow-positive and management projects it will become a meaningful revenue stream alongside ETST's compounding and DTC divisions, which reported $25.9 million revenue for the nine months ended December 31, 2025.
Earth Science Tech (OTC: ETST) announced strategic portfolio, governance and capital-discipline initiatives aimed at positioning the company as an institutional-ready public company.
Management reported $3.3M net income for fiscal 2025 and expects approximately $1.4M in annualized cost savings for fiscal 2026, supporting an anticipated ~40%+ net income increase to $4.7M on a go-forward basis.
Key steps include divesting non-core assets, consolidating subsidiaries, introducing advisory shareholder votes (including say-on-pay and Series B retirement), executives voiding employment contracts to reduce costs, and reduced board compensation.